(Press-News.org) The African CDC has recently warned of a surge in cholera cases across the continent. Cholera, caused by certain strains of V. cholerae, is a waterborne infection that spreads rapidly, particularly in areas with limited access to clean water and sanitation. Africa bears the majority of the global burden of cholera, accounting for 46% of all cases and nearly 83% of all deaths. Yet, only about 1.3% of laboratories on the continent have the bacteriology capacity to confirm infections.
In 2024, representatives from 14 African countries came together for a five-day intensive workshop on a whole-genome sequencing method called Oxford Nanopore Technology (ONT) aimed at strengthening cholera surveillance capabilities across the continent. The event was organised by PulseNet Africa, a network dedicated to combating food- and waterborne diseases, and hosted at the Medical Research Council Unit the Gambia at the London School of Hygiene and Tropical Medicine (LSHTM).
“The hands-on training approach—where scientists brought DNA from their own archived, previously unsequenced isolates and used these real samples to learn the complete workflow—proved exceptionally valuable,” says Dr Ebenezer Foster-Nyarko, a Research Fellow at LSHTM, Regional Co-Coordinator for PulseNet Africa and lead author of the study. “This comprehensive approach helped demystify genomic surveillance and demonstrated its immediate practical applications for public health.”
The study, published in Microbial Genomics, analysed whole genome data from 104 isolates between 2010 and 2024 across Cote d'Ivoire, Ghana, Zambia, and South Africa. Findings highlight substantial genetic diversity, the presence of distinct local clades, and widespread multi-drug resistance to commonly used antibiotics, such as quinolones and trimethoprim. In contrast, resistance to azithromycin and rifampicin remains low. According to Foster-Nyarko, this pattern reflects decades of heavy reliance on trimethoprim and quinolones in Africa and Asia, whereas azithromycin and rifampicin have only recently been introduced. “This emphasises the urgent need for antimicrobial stewardship—preserving the effectiveness of remaining treatment options is critical to preventing further resistance,” he notes.
Although limited by the scarcity of available genomic data, the study provides an important snapshot of a wider issue. Continued capacity building through training workshops and establishing sustained regional collaborations will be vital, says Foster-Nyarko.
The success of the 2024 workshop has already catalysed significant developments in disease surveillance across Africa; “PulseNet Africa launched feasibility studies in January 2025 to enhance genomic monitoring of PulseNet pathogens, with particular emphasis on antimicrobial resistance,” says Foster-Nyarko. These efforts will expand ONT sequencing capacity beyond cholera to other foodborne diseases.
“By building local expertise in genomic surveillance, African countries will have the tools and skills needed to independently monitor and respond to cholera and other foodborne pathogens, ultimately contributing to long-term improvements in public health systems across the continent.”
About the Microbiology Society
The Microbiology Society is a not-for-profit publisher and membership charity for scientists interested in microbes, their effects and their practical uses. It has a worldwide membership based in universities, industry, hospitals, research institutes, schools, and other organisations. Find out more at microbiologysociety.org. For any queries please contact press@microbiologysociety.org.
About Microbial Genomics
Part of the Microbiology Society’s publishing portfolio, Microbial Genomics is the Open Access journal of choice for pioneering research on genomics, fully supported by innovative, collaborative services. Find out more at microbiologyresearch.org.
END
Persistent antibiotic resistance of cholera-causing bacteria in Africa revealed from a multinational workshop for strengthening disease surveillance
2025-12-10
ELSE PRESS RELEASES FROM THIS DATE:
SwRI, Trinity University to synthesize novel compound to mitigate effects of stroke, heart attack
2025-12-10
SAN ANTONIO — December 10, 2025 — Southwest Research Institute (SwRI) and Trinity University will improve a prodrug, a compound activated in the body, to mitigate tissue and organ damage associated with heart attacks, strokes and traumatic injuries. These conditions cause a lack of blood flow, but treatment to reverse blockages can also lead to lasting damage.
A project collaboratively funded by SwRI and Trinity will address both the initial lack of blood (ischemia) and the rush of blood that follows treatment (reperfusion) referred to as ischemia/reperfusion injury (IRI).
“The moment oxygen comes flooding back ...
Novel endocrine therapy giredestrant improves disease-free survival over standard of care for patients with early-stage breast cancer in phase III lidERA trial
2025-12-10
SAN ANTONIO – The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with the current standard-of-care endocrine therapy in patients with early-stage, hormone receptor (HR)-positive, HER2-negative breast cancer, according to the results of the phase III IidERA trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.
“For patients with HR-positive breast cancer—which accounts for about 70% of breast cancer ...
Gen Z views world as "scary place" with growing cynicism about ability to create change
2025-12-10
Washington, D.C. December 10, 2025 – Gen Z views the world as a scary place, according to new research presented at the 2025 Society for Risk Analysis Conference. In ongoing research that began in Fall 2022, Gabriel Rubin, Ph.D. a justice studies professor at Montclair State University, has now conducted 104 long-form interviews with Gen Z young people in the Northeast United States about their views on politics, risk and protest—expanding on his initial findings from the study, Gen Z Risk Perceptions: ...
Biosensor performance doubled – New applications possible
2025-12-10
• Measurement accuracy of oxidase biosensors for glucose, lactate, and creatinine increased from about 50 to 99 percent
• Oxygen previously caused inaccuracies; the new method removes oxygen
• Researchers see potential applications ranging from personalized medicine to agriculture
Biosensors are helping people with chronic conditions worldwide live better lives. However, their measurement accuracy has often been relatively low, limiting the range of possible applications. ...
Leveraging incomplete remote sensing for forest inventory
2025-12-10
Researchers have harnessed a new statistical technique that allows forest managers to use incomplete satellite imagery for precise forest inventories, bypassing the need for complex and often uncertain data repair processes. The method, known as a "hybrid estimator," is particularly valuable for leveraging decades of archived data from the aging Landsat 7 satellite, which has been collecting images with systematic gaps since 2003.
The study, published in Forest Ecosystems, addresses a critical challenge in forestry and climate science. Remote sensing is vital for large-scale ...
Key chemical in dark chocolate may slow down ageing
2025-12-10
A chemical found in dark chocolate could slow the rate of biological ageing.
Research from King’s College London has found that the chemical theobromine, a common plant compound that comes from cocoa, could have anti-ageing properties.
The study, published today in Aging, compared levels of theobromine in people’s blood, with blood-based markers of biological ageing.
Biological age markers indicate how old your body seems based on its health and function, as opposed to the years you have lived. These markers ...
New 15-minute hepatitis C test paves the way for same-day treatment
2025-12-10
Chronic hepatitis C infection affects an estimated 50 million people globally, causes approximately 242,000 deaths per year mostly due to cirrhosis and liver cancer
Same-day results will help kickstart treatment for infection, which is curable with medication
Johns Hopkins scientists independently confirmed test’s 100% agreement when compared to commercial platforms
CHICAGO --- Scientists at Northwestern University have developed the fastest test yet for diagnosing hepatitis C virus (HCV). The highly accurate diagnostic delivers results to patients in just 15 minutes — up to 75% faster than other rapid HCV tests. This ...
Uranus and Neptune might be rock giants
2025-12-10
The planets in the Solar System are typically divided into three categories based on their composition: the four terrestrial rocky planets (Mercury, Venus, Earth and Mars), followed by the two gas giants (Jupiter and Saturn), and finally two ice giants (Uranus and Neptune). According to the work carried by the UZH scientific team, Uranus and Neptune might actually be more rocky than icy. The new study does not claim the two blue planets to be one or the other type, water- or rock- rich, it rather challenges that ...
Magnetically actuated soft electrodes for multisite bioelectrical monitoring of ex vivo tissues
2025-12-10
Ex vivo cultured organoids, tissue slices, and isolated organs are essential models for studying disease mechanisms and evaluating drug responses. Real-time, multisite electrophysiological monitoring is critical for capturing their dynamic behavior. However, conventional microelectrode arrays are limited in dynamic environments due to rigid structures, fixed electrode layouts, and cable constraints. Advances in soft, stretchable electronics offer solutions, but most devices lack active repositioning capabilities. “Magnetically actuated soft robots ...
FAU engineers decode dementia type using AI and EEG brainwave analysis
2025-12-10
Dementia is a group of disorders that gradually impair memory, thinking and daily functioning. Alzheimer’s disease (AD), the most common form of dementia, affects about 7.2 million Americans aged 65 and older in 2025. Frontotemporal dementia (FTD), while rarer, is the second most common cause of early-onset dementia, often striking people in their 40s to 60s.
Although both diseases damage the brain, they do so in distinct ways. AD primarily affects memory and spatial awareness, while FTD targets regions responsible for behavior, personality and language. Because their symptoms can overlap, it often leads to misdiagnosis. ...